Nasus Pharma Ltd.

NSRX | AMEX

Price Alert Chart Builder DCF Calculator

$3.16

-$0.15 (-4.53%)

At close: Oct 30, 2026, 3:59 PM ET

$3.16

$0.00 (0.00%)

After-hours: Oct 30, 2026, 3:59 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-4.53%

(1D)

No price chart data available for 1D timeframe.

Rating

Updated: Nov 2, 2026

25.5

+3.0 pts

Fundamentals Weak

Market Sentiment Neutral

Moat None

Sector Rank #909/1028 (Top 88%)

Full Analysis

Key Statistics

Market Data

Market Cap $27.22M

1D Range

3.13 3.27

52W Range

2.01 9.15

Valuation (TTM)

PE -3.29

PB 2.48

EV/EBITDA -2.16

Valuation (NTM)

Forward PE N/A

Forward PEG -0.05

Price Target $22.00

Cash Flow

FCF Yield -12.4%

SBC Adj. FCF Yield -12.4%

SBC Impact 0.0%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y -76.6% | N/A

FCF 3Y | 5Y -144.7% | N/A

Returns

ROA -87.8%

ROE -158.8%

ROIC -96.5%

Financial Health

Net Cash

$11.82M

Current Ratio 8.77

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Nasus Pharma Ltd., a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. It offers Powder-Based Intranasal (PBI) produ...

Sector Healthcare

Industry Medical - Pharmaceuticals

Employees 7

IPO Date Aug 13, 2025

Website www.nasuspharma.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$22.00

Upside

+596.20%

Buy (1)

Hold (0)

Sell (0)

Analyst Details ➞